Health and Healthcare

Abbott Laboratories : ABT

All Abbott Laboratories Articles

311 Articles

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Nov 30, 2007 at 4:21 AM EST

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Fed chief Bernanke said the resurgence in financial strains in recent weeks had dimmed the outlook for…

Douglas A. McIntyre | Nov 29, 2007 at 6:47 PM EST

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Jul 18, 2007 at 7:15 AM EDT

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items;…

Douglas A. McIntyre | Jul 13, 2007 at 4:58 PM EDT

Top Earnings Next Week Part 1 (July 16-18, 2007)

MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM…

Douglas A. McIntyre | Jul 12, 2007 at 5:05 AM EDT

Another Reason Wall St. Hates GE (GE)

GE’s (GE) share price has had a bit of a run over the last three months. Until that point, the…

Douglas A. McIntyre | Jul 12, 2007 at 3:16 AM EDT

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 22, 2007 at 4:36 PM EDT

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw…

1 … 19 20 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

Top Earnings Next Week Part 1 (July 16-18, 2007)

Another Reason Wall St. Hates GE (GE)

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Short Selling Up in Drug & Medical Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

Top Earnings Next Week Part 1 (July 16-18, 2007)

Another Reason Wall St. Hates GE (GE)

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Short Selling Up in Drug & Medical Stocks

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s